These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12780410)

  • 1. Measuring visual field progression in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Bengtsson B; Hussein M;
    Acta Ophthalmol Scand; 2003 Jun; 81(3):286-93. PubMed ID: 12780410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
    Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Functional Progression in the Early Manifest Glaucoma Trial.
    Öhnell H; Heijl A; Brenner L; Anderson H; Bengtsson B
    Ophthalmology; 2016 Jun; 123(6):1173-80. PubMed ID: 26949119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of glaucoma progression by perimetry and optic disc photography at different stages of the disease: results from the Early Manifest Glaucoma Trial.
    Öhnell H; Heijl A; Anderson H; Bengtsson B
    Acta Ophthalmol; 2017 May; 95(3):281-287. PubMed ID: 27778463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
    Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
    Leske MC; Heijl A; Hussein M; Bengtsson B; Hyman L; Komaroff E;
    Arch Ophthalmol; 2003 Jan; 121(1):48-56. PubMed ID: 12523884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
    Musch DC; Gillespie BW; Lichter PR; Niziol LM; Janz NK;
    Ophthalmology; 2009 Feb; 116(2):200-7. PubMed ID: 19019444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
    Kiuchi T; Motoyama Y; Oshika T
    Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mitomycin C trabeculectomy on the progression of visual field defect in normal-tension glaucoma.
    Hagiwara Y; Yamamoto T; Kitazawa Y
    Graefes Arch Clin Exp Ophthalmol; 2000 Mar; 238(3):232-6. PubMed ID: 10796038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.
    Am J Ophthalmol; 2000 Oct; 130(4):429-40. PubMed ID: 11024415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and long term progression in open angle glaucoma patients.
    Pantalon AD; Feraru C; Chiseliţă D
    Rom J Ophthalmol; 2016; 60(3):174-180. PubMed ID: 29450344
    [No Abstract]   [Full Text] [Related]  

  • 20. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
    Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
    Ophthalmology; 2013 Dec; 120(12):2540-2545. PubMed ID: 24126032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.